Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We on Agoracom are often MYOPIC! - PR v no PR

An average investment of $40K in a 12 cent stock that has essentially zero institutional or insider ownership doesn't surprise you? It does me. Especially when you take into account that that's an analysis of the number of shareholders based on a share price of 10 cents when for periods of time, the stock traded at much higher values. IMO, to think that all 405M shares are spread out over only 1000 people seems very unrealistic.

Consider for a moment if:

50 people owned ON AVERAGE 2M shares each. That would take up 100M shares.

100 people owned ON AVERAGE 500K shares each. That would take up the next 50M shares

200 people owned ON AVERAGE 100K shares each. That would take up the next 20M shares

500 people owned ON AVERAGE 50K shares each. That would take up the next 25M shares

If there were only 1000 shareholders, that would leave only 150 people left to spread the next 210M shares meaning that those people would need to own 1.4M shares each.


I'd be surprised to find out that 3/4 of the company float would be controlled by only 200 people or so.

Share
New Message
Please login to post a reply